Using CRISPR-Cas9 gene editing to treat muscle wasting diseases

CRISPR-Cas9 genomic editing may provide permanent solutions for muscular dystrophies, a group of rare genetic disorders characterized by muscle weakness and degeneration.

• Muscular dystrophies are caused by mutations in genes responsible for muscle function.
• Current treatments for these disorders are not curative and often require repetitive therapies.
• The CRISPR-Cas9 system allows for stable editing of the genome, potentially reducing the need for ongoing treatments.
• Recent studies have shown promising advances in the application of CRISPR-Cas9 for treating genetic muscular dystrophies.

Simplified